Swelling lecithin: Cholesterol implants for the controlled release of proteins

Journal of Liposome Research

Volumn 19, Issue 1, 2009, Pages 37-48

  Tantipolphan, Ruedeeporn ^a   Rades, Thomas ^a   Medlicott, Natalie J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Controlled release; Lecithin:cholesterol; Protein; Salt; Solid implants; Swellable

Indexed keywords

BOVINE SERUM ALBUMIN; CALCIUM CHLORIDE; CHOLESTEROL; MONOMER; MYELIN; PHOSPHATIDYLCHOLINE; SODIUM CHLORIDE;

ARTICLE; CONTROLLED STUDY; HYDRATION; IN VITRO STUDY; LIPID VESICLE; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN SECRETION; PROTEIN STRUCTURE; SWELLING; ANIMAL; BIODEGRADABLE IMPLANT; CATTLE; CHEMISTRY; DELAYED RELEASE FORMULATION;

ABSORBABLE IMPLANTS; ANIMALS; CALCIUM CHLORIDE; CATTLE; CHOLESTEROL; DELAYED-ACTION PREPARATIONS; LECITHINS; SERUM ALBUMIN, BOVINE; SODIUM CHLORIDE;

EID: 70349571739     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100802636434     Document Type: Article

References (38)

1. Appel B, Maschke A, Weiser B, Sarhan H, Englert C, Angele P, et al. (2006). Lipidic implants for controlled release of bioactive insulin: effects on cartilage engineered in vitro. Int J Pharm 314:170-178.
2. 2+ dependent interaction of Annexin V with phospholipid membranes: a combined study uisng fluorescence techniques, microelectrophoresis, and infrared spectroscopy. Phys Chem Chem Phys 2:4615-4623.
3. Binder H, Zschornig O. (2002). The effect of metal cations on the phase behavior and hydration characteristics of phospholipid membranes. Chem Phys Lipids 115:39-61.
4. Casal HL, Mantsch HH. (1984). Polymorphic phase behaviour of phospholipid membranes studied by infrared spectroscopy. Biochim Biophys Acta 779:381-401.
5. Cevc G. (1993). Phospholipids Handbook. New York: Marcel Dekker, Inc.
6. Colombo P, Bettini R, Massimo G, Catellani PL, Santi P, Peppas NA. (1995). Drug diffusion front movement is important in drug release control from swellable matrix tablets. J Pharm Sci 84:991-997.
7. Colombo P, Bettini R, Santi P, Peppas NA. (2000). Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms, and optimal performance. Pharm Sci Technol Today 3:198-204.
8. Crotts G, Park TG. (1997). Stability and release of bovine serum albumin encapsulated within poly(D, L-lactide-co-glycolide) microparticles. J Cont Rel 44:123-134.
9. Estey T, Kang J, Schwendeman SP, Carpenter JF. (2006). BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems. J Pharm Sci 95:1626-1639.
10. Garcia-Manyes S, Oncins G, Sanz F. (2005). Effect of ion-binding and chemical phospholipid structure on the nanomechanics of lipid bilayers studied by force spectroscopy. Biophys J 89:1812-1826.
11. Grdadolnik J, Hadzi D. (1993). Conformational effects of metal salt binding to the polar head of phosphatidylcholines investigated by FTIR spectroscopy. Chem Phys Lipids 65:121-132.
12. Guse C, Koennings S, Kreye F, Siepmann F, Goepferich A, Siepmann J. (2006). Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms. Int J Pharm 314:137-144.
13. Herrmann S, Mohl S, Siepmann F, Siepmann J, Winter G. (2007a). New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implants. Pharm Res 24:1527-1537.
14. Herrmann S, Winter G, Mohl S, Siepmann F, Siepmann J. (2007b). Mechanisms controlling protein release from lipidic implants: effects of PEG addition. J Contr Rel 118:161-168.
15. Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. (2003). Physicochemical stability of colloidal lipid particles. Biometerials 24:4283-4300.
16. Hubner W, Blume A. (1998). Interactions at the lipid-water interface. Chem Phys Lipids 96:99-123.
17. Kendrick BS, Dong A, Allison SD, Manning MC, Carpenter JF. (1996). Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states. J Pharm Sci 85:155-158.
18. Khan MZI, Tucker IG, Opdebeeck JP. (1991). Cholesterol and lecithin implants for sustained release of antigen: release and erosion in vitro, and antibody response in mice. Int J Pharm 76:161-170.
19. Khan MZI, Tucker IG, Opdebeeck, JP.(1993). Evaluation of cholesterol- lecithin implants for sustained delivery of antigen: release in vivo and single-step immunisation of mice. Int J Pharm 90:255-262.
20. Koennings S, Garcion E, Faisant N, Menei P, Benoit JP, Gopferich A. (2006). In vitro investigation of lipid implants as a controlled release system for interleukin-18. Int J Pharm 314:145-152.
21. Korreman SS, Posselt D. (2001). Modification of anomalous swelling in multilamellar vesicles induced by alkali halide salts. Eur Biophys J 30:121-128.
22. Koynova R, Caffrey M. (1998). Phases and phase transitions of the phosphatidylcholines. Biochim Biophys Acta 1376:91-145.
23. Lis LJ, Parsegian VA, Rand RP. (1981). Binding of divalent cations of dipalmitoylphosphatidylcholine bilayers and its effect on bilayer interaction. Biochemistry 20:1761-1770.
24. Mohl S, Winter G. (2004). Continuous release of rh-interferon alpha-2a from triglyceride matrices. J Contr Rel 97:67-78.
25. Mohl S, Winter G. (2006). Continuous release of rh-interferon (alpha-2a from triglyceride implants: storage stability of the dosage forms. Pharm Dev Technol 11:103-110.
26. Petrache HI, Tristram-Nagle S, Harries D, Kucerka N, Nagle JF, Parsegian VA. (2006). Swelling of phospholipids by monovalent salt. J Lipid Res 47:302-309.
27. Pongjanyakul T, Medlicott NJ, Tucker IG. (2004). Melted glyceryl palmitostearate (GPS) pellets for protein delivery. Int J Pharm 271:53-62.
28. Reithmeier H, Herrmann J, Gopferich A. (2001). Lipid microparticles as a parenteral controlled release device for peptides. J Contr Rel 73:339-350.
29. Schule S, Friess W, Bechtold-Peters K, Garidel P. (2007). Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations. Eur J Pharm Biopharm 65:1-9.
30. Selle C, Pohle W. (1998). Fourier transform infrared spectroscopy as a probe for the study of the hydration of lipid self-assemblies. II. Water binding versus phase transitions. Biospectroscopy 4:281-294.
31. Small DM. (1986). Handbook of Lipid Research. New York: Plenum Press.
32. Tamber H, Johansen P, Merkle HP, Gander B. (2005). Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 57:357-376.
33. Tamm LK, Tatulian SA. (1997). Infrared spectroscopy of proteins and peptides in lipid bilayers. Quart Rev Biophys 30:365-429.
34. Tang W, Ciftci K. (2006). Commonly used analytical techniques for biotechnology products. In: (ed.) Groves MJ, Pharmaceutical Biotechnology (pp 147-178). Boca Raton: Taylor & Francis.
35. Tantipolphan R, Rades T, McQuilan AJ, Medlicott NJ. (2007). Adsorption of bovine serum albumin (BSA) onto lecithin studied by attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy. Int J Pharm 337:40-47.
36. Tardi C, Brandl M, Schubert R. (1998). Erosion and controlled release properties of semisolid vesicular phospholipid dispersions. J Contr Rel 55:261-270.
37. Walduck AK, Opdebeeck JP, Benson HE, Prankerd R. (1998). Biodegradable implants for the delivery of veterinary vaccines: design, manufacture, and antibody responses in sheep. J Contr Rel 51:269-280.
38. Wang W. (1999). Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm 185:129-188.